Disruptive Immunology

Clin Cancer Res. 2016 Apr 15;22(8):1844. doi: 10.1158/1078-0432.CCR-15-1850.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Immunomodulation / drug effects*
  • Immunotherapy
  • Neoplasms / immunology*
  • Neoplasms / therapy*

Substances

  • Antineoplastic Agents